VIR BIOTECHNOLOGY INC's ticker is VIR and the CUSIP is 92764N102. A total of 215 filers reported holding VIR BIOTECHNOLOGY INC in Q2 2022. The put-call ratio across all filers is 0.76 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2023 | $1,806,415 | -7.1% | 73,641 | -11.9% | 0.00% | 0.0% |
| Q1 2023 | $1,944,464 | -61.2% | 83,561 | -57.8% | 0.00% | -63.6% |
| Q4 2022 | $5,011,127 | -25.0% | 197,990 | -42.8% | 0.01% | -26.7% |
| Q3 2022 | $6,678,000 | +2.4% | 346,276 | +35.2% | 0.02% | +15.4% |
| Q2 2022 | $6,524,000 | -55.8% | 256,076 | -27.3% | 0.01% | -51.9% |
| Q4 2021 | $14,746,000 | +478.0% | 352,171 | +500.8% | 0.03% | +145.5% |
| Q3 2021 | $2,551,000 | +25.8% | 58,619 | +48.2% | 0.01% | +22.2% |
| Q1 2021 | $2,028,000 | – | 39,560 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Bill & Melinda Gates Foundation | 1,559,142 | $36,281,234 | 32.04% |
| SB INVESTMENT ADVISERS (UK) LTD | 18,319,938 | $426,304,957 | 3.50% |
| Zebra Capital Management LLC | 27,110 | $631 | 3.15% |
| Avidity Partners Management LP | 1,640,200 | $38,167,454 | 1.27% |
| Sofinnova Investments, Inc. | 657,559 | $15,301,398 | 0.98% |
| DCF Advisers, LLC | 62,000 | $1,442,740 | 0.88% |
| SECTOR GAMMA AS | 145,545 | $3,386,832 | 0.82% |
| Temasek Holdings (Private) Ltd | 5,814,972 | $135,314,398 | 0.80% |
| BRAIDWELL LP | 604,036 | $14,055,918 | 0.46% |
| SummerHaven Investment Management, LLC | 26,045 | $606,067 | 0.35% |